RA

Renu Agrawal

Active Director Director DIN 00164919
DIN 00164919 First appointment Jun 2006 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2006
Shareholding value •••• Premium profile

About Renu Agrawal

Data last updated:

Renu Agrawal is a Director at Mahamrityunjaya Hospital Private Limited (since 2006). The company operates in Healthcare. Mahamrityunjaya Hospital Private Limited reported revenue of ₹5.24 Cr (FY 2024).

DIN 00164919
Primary Designation Director
Industry Healthcare
First Appointment 01 Jun 2006
Oldest Company Age 20 yrs
Largest company Mahamrityunjaya Hospital Private Limited · ₹5.24 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20062006₹5.24 Cr (FY 2024)Active

Directorship timeline

Open interactive timeline →
Mahamrityunjaya Hospital Private Limited
Premium access

Shareholding and investment profile for Renu Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Renu Agrawal

Renu Agrawal currently holds 1 directorship: Mahamrityunjaya Hospital Private Limited (Director, since 01 Jun 2006, revenue ₹5.24 Cr (FY 2024)).

Renu Agrawal was first appointed on 01 Jun 2006 as Director at Mahamrityunjaya Hospital Private Limited.

The current boards of Renu Agrawal's companies include Arpit Agrawal (Mahamrityunjaya Hospital Private Limited), Mahesh Agrawal (Mahamrityunjaya Hospital Private Limited), Megha Agrawal (Mahamrityunjaya Hospital Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available